Literature DB >> 2451478

Fc gamma receptors on keratinocytes in psoriasis.

J K Livden1.   

Abstract

Epidermis in cryostat sections of skin biopsy specimens from patients with psoriasis and from healthy individuals bound bovine erythrocytes (E) sensitized with rabbit IgG antibodies (A)(EA). No binding occurred using E or E sensitized with IgM or F(ab')2 fragments of IgG. The binding of EA was inhibited by human IgG and by Fc fragments of IgG, whereas human IgA, IgM, albumin, and F(ab)2 fragments of IgG did not inhibit the binding, indicating the presence of receptors for the Fc part of IgG (FcR). EA bound mainly to stratum spinosum and most strongly above FcR-positive cell infiltrates in dermal papillae. The binding of EA to sections from patients with active psoriasis was stronger than to sections from patients with stationary psoriasis vulgaris. Sections of unaffected skin from patients with psoriasis and healthy individuals also bound EA, but the binding was weaker than to sections of psoriatic lesions. The receptors were sensitive to periodic acid, formaldehyde, and heat. Using immune complexes of horseradish peroxidase (HRP) and rabbit IgG antibodies to HRP, the receptors were localized to the outer aspect of the keratinocytes and to the inflammatory cells in the microabscesses. The strongest binding occurred in the same areas which adhered EA most strongly. FcR on dendritic epidermal cells could not be demonstrated in situ. A monoclonal antibody against FcR also stained the outer aspect of most keratinocytes throughout the epidermis. FcR on keratinocytes support the assumption that these cells contribute to immune reactions in the skin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2451478     DOI: 10.1007/bf00412682

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  23 in total

1.  The placental Fcgamma receptors studied using immune complexes of peroxidase.

Authors:  R Matre; A Haugen
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

2.  Immunoglobulins and anti-immunoglobulin factors in psoriatic lesions.

Authors:  H K Krogh; O Tönder
Journal:  Clin Exp Immunol       Date:  1972-04       Impact factor: 4.330

3.  Crystallization of fragment Fab of human IgG myeloma proteins.

Authors:  G Rossi; A Nisonoff
Journal:  Biochem Biophys Res Commun       Date:  1968-06-28       Impact factor: 3.575

4.  Virus replication and induction of interferon in human epidermal keratinocytes following infection with herpes simplex virus.

Authors:  L E Schnipper; M Levin; C S Crumpacker; B A Gilchrest
Journal:  J Invest Dermatol       Date:  1984-01       Impact factor: 8.551

5.  Localization of Fc gamma receptors in the human central nervous system.

Authors:  H Nyland; R Nilsen
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1982-08

6.  Factors mediating the binding of immune complexes to cryostat sections of psoriatic lesions.

Authors:  J R Bjerke; H K Krogh; R Matre
Journal:  Int Arch Allergy Appl Immunol       Date:  1982

7.  Properties of Fc gamma receptors in the human central nervous system.

Authors:  H Nyland
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1982-06

8.  Human keratinocytes express HLA-DR antigens in the tuberculin reaction.

Authors:  A Scheynius; U Tjernlund
Journal:  Scand J Immunol       Date:  1984-02       Impact factor: 3.487

9.  Specificity of Fcgamma receptors in human malignant tissue and normal lymphoreticular tissue.

Authors:  R Matre
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

10.  MIXED AGGLUTINATION WITH TISSUE SECTIONS.

Authors:  O TOENDER; F MILGROM; E WITEBSKY
Journal:  J Exp Med       Date:  1964-02-01       Impact factor: 14.307

View more
  5 in total

1.  Properties of solubilized Fc gamma-receptors from psoriatic scales.

Authors:  J K Livden; E K Kristoffersen; R Matre
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

Review 2.  Receptors for gammaglobulin in the central and peripheral nervous system.

Authors:  C Vedeler; E Ulvestad; H Nyland; R Matre; J A Aarli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

3.  Effect of Adalimumab on Gene Expression Profiles of Psoriatic Skin and Blood.

Authors:  Maggie Chow; Kevin Lai; Richard Ahn; Rashmi Gupta; Sarah Arron; Wilson Liao
Journal:  J Drugs Dermatol       Date:  2016-08-01       Impact factor: 2.114

4.  Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions.

Authors:  O J de Boer; C M van der Loos; F Hamerlinck; J D Bos; P K Das
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

5.  In situ localization of interferons in psoriatic lesions.

Authors:  J K Livden; R Nilsen; J R Bjerke; R Matre
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.